Condensed Consolidated Statements of Stockholders' Equity (unaudited) - USD ($) $ in Thousands	Total	Common Stock	Treasury Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021		247,358,412
Beginning balance (in shares) at Dec. 31, 2021			(318,086)
Beginning balance at Dec. 31, 2021	$ 858,510	$ 25	$ (3,020)	$ 1,508,995	$ 0	$ (647,490)
Increase (Decrease) in Stockholders' Deficit [Roll Forward]
Net income (loss)	(3,273)					(3,273)
Share-based payments (in shares)		102,630	21,505
Share-based payments	3,272		$ (287)	3,559
Ending balance (in shares) at Mar. 31, 2022		247,461,042
Ending balance (in shares) at Mar. 31, 2022			(339,591)
Ending balance at Mar. 31, 2022	858,509	$ 25	$ (3,307)	1,512,554	0	(650,763)
Beginning balance (in shares) at Dec. 31, 2021		247,358,412
Beginning balance (in shares) at Dec. 31, 2021			(318,086)
Beginning balance at Dec. 31, 2021	858,510	$ 25	$ (3,020)	1,508,995	0	(647,490)
Increase (Decrease) in Stockholders' Deficit [Roll Forward]
Net income (loss)	10,350
Other comprehensive income (loss)	(2,636)
Ending balance (in shares) at Jun. 30, 2022		248,068,603
Ending balance (in shares) at Jun. 30, 2022			(490,011)
Ending balance at Jun. 30, 2022	870,125	$ 25	$ (4,463)	1,514,339	(2,636)	(637,140)
Beginning balance (in shares) at Mar. 31, 2022		247,461,042
Beginning balance (in shares) at Mar. 31, 2022			(339,591)
Beginning balance at Mar. 31, 2022	858,509	$ 25	$ (3,307)	1,512,554	0	(650,763)
Increase (Decrease) in Stockholders' Deficit [Roll Forward]
Net income (loss)	13,623					13,623
Other comprehensive income (loss)	(2,636)				(2,636)
Share-based payments (in shares)		607,561	150,420
Share-based payments	629		$ (1,156)	1,785
Ending balance (in shares) at Jun. 30, 2022		248,068,603
Ending balance (in shares) at Jun. 30, 2022			(490,011)
Ending balance at Jun. 30, 2022	$ 870,125	$ 25	$ (4,463)	1,514,339	(2,636)	(637,140)
Beginning balance (in shares) at Dec. 31, 2022	248,311,104	248,311,104
Beginning balance (in shares) at Dec. 31, 2022	(2,241,069)		(2,241,069)
Beginning balance at Dec. 31, 2022	$ 888,443	$ 25	$ (15,537)	1,521,487	(8,947)	(608,585)
Increase (Decrease) in Stockholders' Deficit [Roll Forward]
Net income (loss)	13,800					13,800
Other comprehensive income (loss)	342				342
Common stock repurchase (in shares)			(174,744)
Common stock repurchase	(1,122)		$ (1,122)
Share-based payments (in shares)		130,484	11,582
Share-based payments	3,374		$ (77)	3,451
Ending balance (in shares) at Mar. 31, 2023		248,441,588
Ending balance (in shares) at Mar. 31, 2023			(2,427,395)
Ending balance at Mar. 31, 2023	$ 904,837	$ 25	$ (16,736)	1,524,938	(8,605)	(594,785)
Beginning balance (in shares) at Dec. 31, 2022	248,311,104	248,311,104
Beginning balance (in shares) at Dec. 31, 2022	(2,241,069)		(2,241,069)
Beginning balance at Dec. 31, 2022	$ 888,443	$ 25	$ (15,537)	1,521,487	(8,947)	(608,585)
Increase (Decrease) in Stockholders' Deficit [Roll Forward]
Net income (loss)	25,410
Other comprehensive income (loss)	$ 2,564
Ending balance (in shares) at Jun. 30, 2023	249,361,351	249,361,351
Ending balance (in shares) at Jun. 30, 2023	(3,153,770)		(3,153,770)
Ending balance at Jun. 30, 2023	$ 919,472	$ 25	$ (21,438)	1,530,443	(6,383)	(583,175)
Beginning balance (in shares) at Mar. 31, 2023		248,441,588
Beginning balance (in shares) at Mar. 31, 2023			(2,427,395)
Beginning balance at Mar. 31, 2023	904,837	$ 25	$ (16,736)	1,524,938	(8,605)	(594,785)
Increase (Decrease) in Stockholders' Deficit [Roll Forward]
Net income (loss)	11,610					11,610
Other comprehensive income (loss)	2,222				2,222
Common stock repurchase (in shares)			(505,142)
Common stock repurchase	(3,205)		$ (3,205)
Share-based payments (in shares)		919,763	221,233
Share-based payments	$ 4,008		$ (1,497)	5,505
Ending balance (in shares) at Jun. 30, 2023	249,361,351	249,361,351
Ending balance (in shares) at Jun. 30, 2023	(3,153,770)		(3,153,770)
Ending balance at Jun. 30, 2023	$ 919,472	$ 25	$ (21,438)	$ 1,530,443	$ (6,383)	$ (583,175)